RAC 2.20% $1.78 race oncology ltd

Daniel, are you saying Race is not about pursuing any further a...

  1. 468 Posts.
    lightbulb Created with Sketch. 70
    Daniel, are you saying Race is not about pursuing any further a compelling case for Clinicians to adopt the use of Bisantrene as a single agent? If it makes sense to change why wouldn’t Race keep investing energy to achieve a change in mind set of of the targeted group. In my experience there is always an element of early adaptors to anything new.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.